Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors

NCT01562626 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumors
Neoplasms
Cancer

Interventions

DRUG: APS001F
DRUG: Flucytosine (5-FC)
DRUG: 10% maltose

Sponsor

Anaeropharma Science, Inc.